Qingfa Bu

Key Laboratory Of Liver Transplantation, NHC Key Laboratory Of Liver Transplantation
Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

EGR1 lactylation induces tumor cell senescence and immunosuppressive microenvironment in intrahepatic cholangiocarcinoma.

EGR1 lactylation induces tumor cell senescence and immunosuppressive microenvironment in intrahepatic cholangiocarcinoma.

Journal: Translational oncology

Published: January 21, 2026

Magnesium isoglycyrrhizinate ameliorates acetaminophen-induced acute liver injury with hyperglycaemia by modulating autophagy and oxidative stress in liver-resident macrophages.

Magnesium isoglycyrrhizinate ameliorates acetaminophen-induced acute liver injury with hyperglycaemia by modulating autophagy and oxidative stress in liver-resident macrophages.

Journal: Frontiers in pharmacology

Published: November 11, 2025

Integrated single-cell and spatial transcriptomic profiling reveals that CD177+ Tregs enhance immunosuppression through apoptosis and resistance to immunotherapy in hepatocellular carcinoma.

Integrated single-cell and spatial transcriptomic profiling reveals that CD177+ Tregs enhance immunosuppression through apoptosis and resistance to immunotherapy in hepatocellular carcinoma.

Journal: Oncogene

Published: October 08, 2024

Macrophage ATG16L1 promotes liver regeneration after partial hepatectomy.

Macrophage ATG16L1 promotes liver regeneration after partial hepatectomy.

Journal: JHEP reports : innovation in hepatology

Published: September 15, 2024

E2F2 Reprograms Macrophage Function By Modulating Material and Energy Metabolism in the Progression of Metabolic Dysfunction-Associated Steatohepatitis.

E2F2 Reprograms Macrophage Function By Modulating Material and Energy Metabolism in the Progression of Metabolic Dysfunction-Associated Steatohepatitis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 06, 2024

ATG16L1 Depletion-Mediated Activation of the TRAF1 Signaling in Macrophages Aggravates Liver Fibrosis.

ATG16L1 Depletion-Mediated Activation of the TRAF1 Signaling in Macrophages Aggravates Liver Fibrosis.

Journal: Mediators of inflammation

Published: August 21, 2024

Correspondence to editorial on "Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy".

Correspondence to editorial on "Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy".

Journal: Clinical and molecular hepatology

Published: June 24, 2024

Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy.

Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy.

Journal: Clinical and molecular hepatology

Published: February 13, 2024

Single-cell analysis reveals hypoxia-induced immunosuppressive microenvironment in intrahepatic cholangiocarcinoma.

Single-cell analysis reveals hypoxia-induced immunosuppressive microenvironment in intrahepatic cholangiocarcinoma.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: January 17, 2024

Letter to the Editor: Scavenger receptor a is a major homeostatic regulator that restrains drug-induced liver injury.

Letter to the Editor: Scavenger receptor a is a major homeostatic regulator that restrains drug-induced liver injury.

Journal: Hepatology (Baltimore, Md.)

Published: November 12, 2023

Integrated single-cell transcriptomics reveals the hypoxia-induced inflammation-cancer transformation in NASH-derived hepatocellular carcinoma.

Integrated single-cell transcriptomics reveals the hypoxia-induced inflammation-cancer transformation in NASH-derived hepatocellular carcinoma.

Journal: Cell proliferation

Published: August 21, 2023

Reply to: "Short-term activation of PERK alleviates the progression of experimental non-alcoholic steatohepatitis".

Reply to: "Short-term activation of PERK alleviates the progression of experimental non-alcoholic steatohepatitis".

Journal: Journal of hepatology

Published: August 16, 2023

Showing 1-12 of 17

Last Updated: 09/26/2026